May 05, 2026
Entities representing groups of opioid claimants in the Chapter 11 case of Purdue Pharma have named their representatives on an oversight board created to implement a public repository of documents related to the national opioid epidemic and Purdue's role in the crisis.
May 04, 2026
Purdue Pharma received the green light for a settlement on its road out of Chapter 11, a Texas bankruptcy judge gave the all-clear to Saks Global's plan disclosure, and Spirit Airlines said it would undergo a shutdown instead of a government-backed rescue.
April 30, 2026
Purdue Pharma LP on Thursday secured a New York bankruptcy judge's approval of a $125 million agreement with McKinsey & Co. that settles claims tied to the consulting firm's work advising Purdue on the sale and marketing of opioids, clearing the way for the pharmaceutical company to exit Chapter 11 and put its $7.4 billion bankruptcy plan into effect.
April 28, 2026
OxyContin maker Purdue Pharma LP has to pay a $3.5 billion fine and forfeit an additional $2 billion, more than five years after it pled guilty to criminal charges related to its role in the opioid crisis, a New Jersey federal judge said Tuesday.
April 24, 2026
A New York bankruptcy judge will consider whether the state's attorney general should be a creditor in a Roman Catholic diocese's Chapter 11, Purdue Pharma will receive its criminal sentence, and Saks Global Enterprises LLC will seek court approval of a plan disclosure statement.
April 21, 2026
A New Jersey federal judge delayed Oxycontin maker Purdue Pharma's criminal sentencing by a week, saying rescheduling would give an in-person attendance option to hundreds of observers who tuned in virtually Tuesday.
April 17, 2026
Purdue Pharma will undergo an omnibus hearing and get criminally sentenced, Office Properties Income Trust will seek plan confirmation and Spirit will vie for the all-clear to take a vote on its own plan.
April 13, 2026
Saks and mall owner Simon Property said they are closing in on an agreement resolving a dispute over leases, recycler Aleon Metals received plan approval and the American Bankruptcy Institute reported a first-quarter bump in bankruptcy filings.
April 10, 2026
More than five years after pleading guilty to conspiring to defraud the U.S. government, Purdue Pharma will be sentenced this month, according to a notice filed in the bankruptcy case of the OxyContin maker.
April 09, 2026
Consulting firm McKinsey & Co. has agreed to pay $125 million to former client Purdue Pharma LP to settle potential claims related to its work advising Purdue on the sale and marketing of opioids, tying up another loose end in the nearly seven-year-old Chapter 11 case.